Thanks to our teams and state-of-the-art equipment, our company can produce a wide range of probiotics and postbiotics tailored to specific requirements and deliver high-quality services to our clients.
R&D laboratorySpecialist team in microbiology, focusing on the optimization of your probiotics/ postbiotics and next-generation strains. Expertise in molecular biology and capabilities in genome and genetic characterization.
A factory Equipped with large-scale fermenters and high-performance freeze-drying devices, with the ability to apply designed and optimized efficient production processes and stabilize bioproducts.
Bioprox Healthcare’s pilot facility is crucial for the successful transition of new production processes and technologies from laboratory to commercial scale. Both our R&D and production teams collaborate for a seamless transition.
Bioprox’s services encompass the entire production process, ensuring high-quality outcomes at every stage:
Fermentation using high-capacity and cutting-edge fermenters to cultivate microorganisms under optimal conditions
Separation of biomass by centrifugation or ultrafiltration
High-performance drying step
Grinding under controlled atmosphere with relative humidity and at different granulometries
Blending
single or multi-strains blends with excipients
"With my colleagues, engineers and technicians, we leverage our scientific and technical expertise to develop innovative solutions. With decades of experience in scaling up and industrial operation, we transform laboratory processes into viable industrial processes at our biotechnology plant”.
To support Bioprox's growth, a major expansion of its production site is underway from 2023. By doubling its industrial capacities, the French company will significantly strengthen its position in both national and international markets. This is the third major expansion the plant has undergone since its foundation in 1975.
1975
1985
1998
2003
2009
2011
2016
2019
2021
2023
"The manufacturing site in Noyant is currently undergoing significant expansion.""This initiative is pivotal as we aim to support the average annual growth of 30% witnessed over the past decade. Indeed, the modernisation not only enhances our operational robustness but also underscores our commitment to meeting the growing demand and requirements to a “T”. Bioprox Healthcare has always been able to rely on knowledge of industrial processes and the properties of cultivated microorganisms. We do have this level of technicity thanks to our sister company, Bioprox Cultures, a French specialist in large-scale industrial fermentation since 1975. The company has developed a solid industrial production activity for over 50 bacterial species as well as high-quality consulting services. This expertise is fundamental to enhancing the effectiveness of probiotics in our clients' future products, solidifying Bioprox's position in the competitive landscape of probiotics’ sector."
Eric De Mol, Bioprox Healthcare’s General Manager — January 2024
We maintain high-quality processes in our operations, adhere to current regulatory standards and foster a culture of quality compliance.
Corporate Social Responsibility (CSR) is important to us. Bioprox Healthcare has been awarded the Ecovadis Silver certification. We strive to integrate social and environmental concerns into all our activities.
l Certified ISO 9001 manufacturing site
l Certified FSSC 22000 manufacturing site
l Halal & Kosher productions
l Allergen free
l Non-GMO
Interested by our services ?